Urgent need for guidelines to communicate with children about life threatening conditions
28 March 2019
The global prevalence of life threatening conditions in children and parents makes it an urgent priority to develop child-focused communication guidelines for healthcare professionals to support families in their time of need.
NMDAR-Antibody Encephalitis: A new clinical way to identify patients
25 February 2019
Paper published in Lancet Psychiatry may help with the accurate detection of this form of autoimmune encephalitis
World’s first gene therapy operation for common cause of sight loss carried out
25 February 2019
Researchers in Oxford have carried out the world’s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK’s most common cause of sight loss.
New research to investigate role of blood-brain barrier in neurological conditions
25 February 2019
A new consortium of 27 partners coordinated by the Nuffield Department of Clinical Neurosciences will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative and metabolic diseases.
MRI scans reveal how brain protects memories
25 February 2019
Two distinct parts of the human brain - the neocortex and the hippocampus (a part of the brain involved in higher-order brain functions) - have been shown to help protect our memories from interfering with one another.
New PODCAST series: focused on the mental health needs of refugee children
25 February 2019
This series of programmes covers assessment and then explores the ranges of interventions that can really help refugee children. From individual, such as narrative exposure therapy, to family and school-based interventions that can positively impact on a child’s mental health outcomes.
First evidence of early effects of antidepressant drug treatment on brain responses to anger in depressed adolescents
25 February 2019
Depression is very common in adolescence and is associated with a high risk of recurrence and suicide. Adolescents with depression experience the same symptoms as adults, such as sadness and fatigue, but some key differences exist. Depressed youth often feel irritable rather than or in addition to feeling low.
Cannabis use in teens raises risk of depression in young adults
25 February 2019
Researchers from McGill University and the University of Oxford carried out a systematic review and meta-analysis of the best existing evidence and analysed 23,317 individuals (from 11 international studies) to see whether use of cannabis in young people is associated with depression, anxiety and suicidality in early adulthood.
25th British Isles Research Workshop
22 January 2019
Professor Keith Hawton hosted the 25th British Isles Research Workshop on Suicide and Self-harm in November 2018. An annually held event which brings together researchers from the UK, Ireland and other countries.
Imaging Deep in The Brain
21 December 2018
New in vivo imaging developments from Nigel Emptage's team in the Department of Pharmacology
Is morphine an effective and safe analgesic for premature babies?
13 December 2018
The Lancet has published the results of the Procedural Pain in Premature Infants (Poppi) study, ran by the Paediatric Neuroimaging Group and co-ordinated by the National Perinatal Epidemiology Unit (Clinical Trials Unit).
My Mind Our Humanity
5 November 2018
The University of Oxford, Department of Psychiatry is working with partners to develop and lead The Young People’s Campaign for the Lancet Commission on Global Mental Health and Sustainable Development
Group therapy most effective treatment for anxiety in young people
5 November 2018
Group-based talking therapies shown to be most effective treatment for young people with anxiety disorders.
Death rates from stroke declining across Europe
24 August 2018
New research, published in the European Heart Journal has shown deaths from conditions that affect the blood supply to the brain, such as stroke, are declining overall in Europe but that in some countries the decline is levelling off or death rates are even increasing.